Home/Filings/4/0001104659-20-102268
4//SEC Filing

Aradhye Shreeram 4

Accession 0001104659-20-102268

CIK 0001633070other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:41 PM ET

Size

5.3 KB

Accession

0001104659-20-102268

Insider Transaction Report

Form 4
Period: 2020-09-01
Aradhye Shreeram
EVP & Chief Developmnt Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-09-01+22,00022,000 total
    Exercise: $4.89Exp: 2030-09-01Common Stock (22,000 underlying)
Footnotes (1)
  • [F1]This option shall vest in 1/12th quarterly installments during the twelve quarters following September 1, 2020 and become fully exercisable on September 1, 2023.

Documents

1 file

Issuer

Axcella Health Inc.

CIK 0001633070

Entity typeother

Related Parties

1
  • filerCIK 0001778372

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:41 PM ET
Size
5.3 KB